Urinary Drugs Market - Global Outlook and Forecast 2022-2028

Publisher Name :
Date: 26-Jan-2022
No. of pages: 78

This report contains market size and forecasts of Urinary Drugs in global, including the following market information:

Global Urinary Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Urinary Drugs Market Sales, 2017-2022, 2023-2028, (K MT)

Global top five Urinary Drugs companies in 2021 (%)

The global Urinary Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Urinary Drugs include Sanofi S.A., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Pfizer Inc., Bayer AG, Allergan Plc., Otsuka Pharmaceutical Co., Ltd. and GlaxosmithKline Plc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Urinary Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Urinary Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Urinary Drugs Market Segment Percentages, by Type, 2021 (%)

- Oral

- Injectables

Global Urinary Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Urinary Drugs Market Segment Percentages, by Application, 2021 (%)

- Hospital

- Clinic

- Home Care

Global Urinary Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Urinary Drugs Market Segment Percentages, By Region and Country, 2021 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Urinary Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Urinary Drugs revenues share in global market, 2021 (%)

Key companies Urinary Drugs sales in global market, 2017-2022 (Estimated), (K MT)

Key companies Urinary Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Sanofi S.A.

- Astellas Pharma Inc.

- Daiichi Sankyo Company Limited

- Pfizer Inc.

- Bayer AG

- Allergan Plc.

- Otsuka Pharmaceutical Co., Ltd.

- GlaxosmithKline Plc.

Urinary Drugs Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Urinary Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Urinary Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Urinary Drugs Overall Market Size
2.1 Global Urinary Drugs Market Size: 2021 VS 2028
2.2 Global Urinary Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Urinary Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Urinary Drugs Players in Global Market
3.2 Top Global Urinary Drugs Companies Ranked by Revenue
3.3 Global Urinary Drugs Revenue by Companies
3.4 Global Urinary Drugs Sales by Companies
3.5 Global Urinary Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Urinary Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Urinary Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Urinary Drugs Players in Global Market
3.8.1 List of Global Tier 1 Urinary Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Urinary Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Urinary Drugs Market Size Markets, 2021 & 2028
4.1.2 Oral
4.1.3 Injectables
4.2 By Type - Global Urinary Drugs Revenue & Forecasts
4.2.1 By Type - Global Urinary Drugs Revenue, 2017-2022
4.2.2 By Type - Global Urinary Drugs Revenue, 2023-2028
4.2.3 By Type - Global Urinary Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Urinary Drugs Sales & Forecasts
4.3.1 By Type - Global Urinary Drugs Sales, 2017-2022
4.3.2 By Type - Global Urinary Drugs Sales, 2023-2028
4.3.3 By Type - Global Urinary Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Urinary Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Urinary Drugs Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Home Care
5.2 By Application - Global Urinary Drugs Revenue & Forecasts
5.2.1 By Application - Global Urinary Drugs Revenue, 2017-2022
5.2.2 By Application - Global Urinary Drugs Revenue, 2023-2028
5.2.3 By Application - Global Urinary Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Urinary Drugs Sales & Forecasts
5.3.1 By Application - Global Urinary Drugs Sales, 2017-2022
5.3.2 By Application - Global Urinary Drugs Sales, 2023-2028
5.3.3 By Application - Global Urinary Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Urinary Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Urinary Drugs Market Size, 2021 & 2028
6.2 By Region - Global Urinary Drugs Revenue & Forecasts
6.2.1 By Region - Global Urinary Drugs Revenue, 2017-2022
6.2.2 By Region - Global Urinary Drugs Revenue, 2023-2028
6.2.3 By Region - Global Urinary Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Urinary Drugs Sales & Forecasts
6.3.1 By Region - Global Urinary Drugs Sales, 2017-2022
6.3.2 By Region - Global Urinary Drugs Sales, 2023-2028
6.3.3 By Region - Global Urinary Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Urinary Drugs Revenue, 2017-2028
6.4.2 By Country - North America Urinary Drugs Sales, 2017-2028
6.4.3 US Urinary Drugs Market Size, 2017-2028
6.4.4 Canada Urinary Drugs Market Size, 2017-2028
6.4.5 Mexico Urinary Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Urinary Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Urinary Drugs Sales, 2017-2028
6.5.3 Germany Urinary Drugs Market Size, 2017-2028
6.5.4 France Urinary Drugs Market Size, 2017-2028
6.5.5 U.K. Urinary Drugs Market Size, 2017-2028
6.5.6 Italy Urinary Drugs Market Size, 2017-2028
6.5.7 Russia Urinary Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Urinary Drugs Market Size, 2017-2028
6.5.9 Benelux Urinary Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Urinary Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Urinary Drugs Sales, 2017-2028
6.6.3 China Urinary Drugs Market Size, 2017-2028
6.6.4 Japan Urinary Drugs Market Size, 2017-2028
6.6.5 South Korea Urinary Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Urinary Drugs Market Size, 2017-2028
6.6.7 India Urinary Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Urinary Drugs Revenue, 2017-2028
6.7.2 By Country - South America Urinary Drugs Sales, 2017-2028
6.7.3 Brazil Urinary Drugs Market Size, 2017-2028
6.7.4 Argentina Urinary Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Urinary Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Urinary Drugs Sales, 2017-2028
6.8.3 Turkey Urinary Drugs Market Size, 2017-2028
6.8.4 Israel Urinary Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Urinary Drugs Market Size, 2017-2028
6.8.6 UAE Urinary Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Sanofi S.A.
7.1.1 Sanofi S.A. Corporate Summary
7.1.2 Sanofi S.A. Business Overview
7.1.3 Sanofi S.A. Urinary Drugs Major Product Offerings
7.1.4 Sanofi S.A. Urinary Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Sanofi S.A. Key News
7.2 Astellas Pharma Inc.
7.2.1 Astellas Pharma Inc. Corporate Summary
7.2.2 Astellas Pharma Inc. Business Overview
7.2.3 Astellas Pharma Inc. Urinary Drugs Major Product Offerings
7.2.4 Astellas Pharma Inc. Urinary Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Astellas Pharma Inc. Key News
7.3 Daiichi Sankyo Company Limited
7.3.1 Daiichi Sankyo Company Limited Corporate Summary
7.3.2 Daiichi Sankyo Company Limited Business Overview
7.3.3 Daiichi Sankyo Company Limited Urinary Drugs Major Product Offerings
7.3.4 Daiichi Sankyo Company Limited Urinary Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Daiichi Sankyo Company Limited Key News
7.4 Pfizer Inc.
7.4.1 Pfizer Inc. Corporate Summary
7.4.2 Pfizer Inc. Business Overview
7.4.3 Pfizer Inc. Urinary Drugs Major Product Offerings
7.4.4 Pfizer Inc. Urinary Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer Inc. Key News
7.5 Bayer AG
7.5.1 Bayer AG Corporate Summary
7.5.2 Bayer AG Business Overview
7.5.3 Bayer AG Urinary Drugs Major Product Offerings
7.5.4 Bayer AG Urinary Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Bayer AG Key News
7.6 Allergan Plc.
7.6.1 Allergan Plc. Corporate Summary
7.6.2 Allergan Plc. Business Overview
7.6.3 Allergan Plc. Urinary Drugs Major Product Offerings
7.6.4 Allergan Plc. Urinary Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Allergan Plc. Key News
7.7 Otsuka Pharmaceutical Co., Ltd.
7.7.1 Otsuka Pharmaceutical Co., Ltd. Corporate Summary
7.7.2 Otsuka Pharmaceutical Co., Ltd. Business Overview
7.7.3 Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Major Product Offerings
7.7.4 Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Otsuka Pharmaceutical Co., Ltd. Key News
7.8 GlaxosmithKline Plc.
7.8.1 GlaxosmithKline Plc. Corporate Summary
7.8.2 GlaxosmithKline Plc. Business Overview
7.8.3 GlaxosmithKline Plc. Urinary Drugs Major Product Offerings
7.8.4 GlaxosmithKline Plc. Urinary Drugs Sales and Revenue in Global (2017-2022)
7.8.5 GlaxosmithKline Plc. Key News
8 Global Urinary Drugs Production Capacity, Analysis
8.1 Global Urinary Drugs Production Capacity, 2017-2028
8.2 Urinary Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Urinary Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Urinary Drugs Supply Chain Analysis
10.1 Urinary Drugs Industry Value Chain
10.2 Urinary Drugs Upstream Market
10.3 Urinary Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Urinary Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Urinary Drugs in Global Market
Table 2. Top Urinary Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Urinary Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Urinary Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Urinary Drugs Sales by Companies, (K MT), 2017-2022
Table 6. Global Urinary Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Urinary Drugs Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Urinary Drugs Product Type
Table 9. List of Global Tier 1 Urinary Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Urinary Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Urinary Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Urinary Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Urinary Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Urinary Drugs Sales (K MT), 2017-2022
Table 15. By Type - Global Urinary Drugs Sales (K MT), 2023-2028
Table 16. By Application - Global Urinary Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Urinary Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Urinary Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Urinary Drugs Sales (K MT), 2017-2022
Table 20. By Application - Global Urinary Drugs Sales (K MT), 2023-2028
Table 21. By Region - Global Urinary Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Urinary Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Urinary Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Urinary Drugs Sales (K MT), 2017-2022
Table 25. By Region - Global Urinary Drugs Sales (K MT), 2023-2028
Table 26. By Country - North America Urinary Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Urinary Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Urinary Drugs Sales, (K MT), 2017-2022
Table 29. By Country - North America Urinary Drugs Sales, (K MT), 2023-2028
Table 30. By Country - Europe Urinary Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Urinary Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Urinary Drugs Sales, (K MT), 2017-2022
Table 33. By Country - Europe Urinary Drugs Sales, (K MT), 2023-2028
Table 34. By Region - Asia Urinary Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Urinary Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Urinary Drugs Sales, (K MT), 2017-2022
Table 37. By Region - Asia Urinary Drugs Sales, (K MT), 2023-2028
Table 38. By Country - South America Urinary Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Urinary Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Urinary Drugs Sales, (K MT), 2017-2022
Table 41. By Country - South America Urinary Drugs Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Urinary Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Urinary Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Urinary Drugs Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Urinary Drugs Sales, (K MT), 2023-2028
Table 46. Sanofi S.A. Corporate Summary
Table 47. Sanofi S.A. Urinary Drugs Product Offerings
Table 48. Sanofi S.A. Urinary Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Astellas Pharma Inc. Corporate Summary
Table 50. Astellas Pharma Inc. Urinary Drugs Product Offerings
Table 51. Astellas Pharma Inc. Urinary Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Daiichi Sankyo Company Limited Corporate Summary
Table 53. Daiichi Sankyo Company Limited Urinary Drugs Product Offerings
Table 54. Daiichi Sankyo Company Limited Urinary Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Pfizer Inc. Corporate Summary
Table 56. Pfizer Inc. Urinary Drugs Product Offerings
Table 57. Pfizer Inc. Urinary Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Bayer AG Corporate Summary
Table 59. Bayer AG Urinary Drugs Product Offerings
Table 60. Bayer AG Urinary Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Allergan Plc. Corporate Summary
Table 62. Allergan Plc. Urinary Drugs Product Offerings
Table 63. Allergan Plc. Urinary Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Otsuka Pharmaceutical Co., Ltd. Corporate Summary
Table 65. Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Product Offerings
Table 66. Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. GlaxosmithKline Plc. Corporate Summary
Table 68. GlaxosmithKline Plc. Urinary Drugs Product Offerings
Table 69. GlaxosmithKline Plc. Urinary Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. Urinary Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 71. Global Urinary Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Urinary Drugs Production by Region, 2017-2022 (K MT)
Table 73. Global Urinary Drugs Production by Region, 2023-2028 (K MT)
Table 74. Urinary Drugs Market Opportunities & Trends in Global Market
Table 75. Urinary Drugs Market Drivers in Global Market
Table 76. Urinary Drugs Market Restraints in Global Market
Table 77. Urinary Drugs Raw Materials
Table 78. Urinary Drugs Raw Materials Suppliers in Global Market
Table 79. Typical Urinary Drugs Downstream
Table 80. Urinary Drugs Downstream Clients in Global Market
Table 81. Urinary Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Urinary Drugs Segment by Type
Figure 2. Urinary Drugs Segment by Application
Figure 3. Global Urinary Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Urinary Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Urinary Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Urinary Drugs Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Urinary Drugs Revenue in 2021
Figure 9. By Type - Global Urinary Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Urinary Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Urinary Drugs Price (USD/MT), 2017-2028
Figure 12. By Application - Global Urinary Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Urinary Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Urinary Drugs Price (USD/MT), 2017-2028
Figure 15. By Region - Global Urinary Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Urinary Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Urinary Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Urinary Drugs Sales Market Share, 2017-2028
Figure 19. US Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Urinary Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Urinary Drugs Sales Market Share, 2017-2028
Figure 24. Germany Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Urinary Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Urinary Drugs Sales Market Share, 2017-2028
Figure 33. China Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Urinary Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Urinary Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Urinary Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Urinary Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Urinary Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Urinary Drugs Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Urinary Drugs by Region, 2021 VS 2028
Figure 50. Urinary Drugs Industry Value Chain
Figure 51. Marketing Channels
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs